GLP1R and Cognitive impairment: Research showed that glucagon-like peptide (GLP-1), which is both a peripherally expressed incretin and a centrally active neuropeptide, may promote neurogenesis, and it ameliorates cognitive deficits in preclinical models of neurodegeneration10–13.